Table 2.

The results of FNAB, histopathology, elastography, ATA and BTA risk stratification systems.

Patient	Sex	Lobe	Nodule Size (mm × mm)	SR	FNAB (Bethesda)	ATA Classification	BTA U Classification	Histopathology
1	F	R	21 × 15	6.3	VI	high suspicion	U 5b	PTC
2	M	R	20 × 17	10	VI	high suspicion	U 5b	PTC
3	F	R	6 × 4.5	2	V	high suspicion	U 4d	PTC
4	F	R	19 × 17	nm	V	high suspicion	U 5a	PTC
5	F	L	12.5 × 10	6	V	high suspicion	U 5b	PTC
6	F	R	7 × 5.7	4.7	IV	high suspicion	U 5a	benign
7	F	R	16 × 16	3.6	IV	high suspicion	U 4b	benign
8	F	R	17.9 × 7.4	4	III	low suspicion	U 2a	benign
9	M	R	6.5 × 4	1.7	III	low suspicion	U 3b	clinical observation
10	M	L	22.6 × 15	2.6	III	low suspicion	U 3c	benign in repeated FNAB
11	F	R	13 × 9.5	nm	III	low suspicion	U 3b	follicular adenoma
12	F	L	7 × 6	nm	III	low suspicion	U 3c	benign in repeated FNAB
13	F	L	12 × 10	6.3	III	low suspicion	U 3b	benign
14	M	R	3.4 × 2	3	III	low suspicion	U 3b	clinical observation
15	F	R	6.8 × 5	1.7	III	high suspicion	U 3c	clinical observation
16	F	R	5.6 × 4.5	1.3	III	low suspicion	U 3c	benign in repeated FNAB
17	F	R	22 × 15	2	III	low suspicion	U 3b	at diagnosis

F—female, M—male, R—right lobe, L—left lobe, SR—strain ratio, nm—not measured, PTC—papillary thyroid cancer.